Skip to Main Content

Paper Details

Small cell transformation of <i>ROS1</i> fusion-positive lung cancer resistant to ROS1 inhibition.
NPJ Precis Oncol
34
2020
ALK, ALK fusion-, EGFR, EGFR-mutant, Patient, Patient-derived models, RB1, ROS1, ROS1 fusion, ROS1 fusion-positive lung cancer, TP53, lung cancer, lung cancers, metastatic tumors, non-small cell to small cell lung cancer, oncogene, patient, small cell lung cancer
Author NameAffiliation
Jochen K LennerzHarvard Medical School
Jochen K LennerzMassachusetts General Hospital
Michael S LawrenceMassachusetts General Hospital
Michael S LawrenceHarvard Medical School
  • 1 - 4

Datasets

Release 1.2